Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis

doi:10.4254/wjh.v13.i9.1190

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5988)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

421

WORD

132

HTML

3198

Figures (1-3)

155

Tables (1-1)

130

Sum=4036

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

359

Download

705

Sum=1064

Publishing Process of This Article

Item

Count

Browse

375

Download

513

Sum=888

Sep 27, 2021 (publication date) through May 3, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Hepatol. Sep 27, 2021; 13(9): 1190-1202
Published online Sep 27, 2021. doi: 10.4254/wjh.v13.i9.1190

Table 1 Summary of meta-analysis results for global seroprevalence of hepatitis B virus serological markers in healthcare workers

	Prevalence % (95%CI)	95% Prediction interval	Studies, n	Participants, n	¹H (95%CI)	²I² (95%CI)	P value (heterogeneity)	P value (Egger test)
Current HBV infection (HBsAg)
Overall	2.4 (2-2.8)	0-11	275	153326	4.1 (4-4.3)	94.1 (93.6-94.5)	< 0.001	< 0.001
Cross-sectional	2.4 (2-2.9)	0-11.1	271	150516	4.1 (4-4.3)	94.2 (93.7-94.6)	< 0.001	< 0.001
Low risk of bias	1.8 (1.4-2.3)	0-8.2	107	40212	3 (2.8-3.2)	88.8 (87-90.3)	< 0.001	< 0.001
Current HBV infection (HBeAg)
Overall	0.3 (0-1.7)	0-70.6	3	4408	3.6 (2.3-5.7)	92.3 (80.7-96.9)	< 0.001	0.577
Cross-sectional	0.3 (0-1.7)	0-70.6	3	4408	3.6 (2.3-5.7)	92.3 (80.7-96.9)	< 0.001	0.577
Low risk of bias	0 (0-0.1)	NA-NA	1	3513	NA (NA-NA)	NA (NA-NA)	1	NA
HBV acute infection
Overall	5.4 (1.4-11.3)	0-37	12	3665	6.1 (5.3-7.1)	97.3 (96.4-98)	< 0.001	0.256
Cross-sectional	5.4 (1.4-11.3)	0-37	12	3665	6.1 (5.3-7.1)	97.3 (96.4-98)	< 0.001	0.256
Low risk of bias	1.9 (0-8.7)	0-48.1	5	1639	6.5 (5.1-8.2)	97.6 (96.2-98.5)	< 0.001	0.824
Immunity against HBV
Overall	56.6 (49.3-63.7)	2.8-100	84	37622	14 (13.5-14.4)	99.5 (99.5-99.5)	< 0.001	0.763
Cross-sectional	56.3 (48.8-63.7)	2.4-100	80	36311	14.2 (13.8-14.7)	99.5 (99.5-99.5)	< 0.001	0.811
Low risk of bias	65.9 (56.1-75.1)	10.3-100	35	22401	14.7 (14.1-15.4)	99.5 (99.5-99.6)	< 0.001	0.974
Immunity due to natural HBV infection
Overall	9.2 (6.9-11.8)	0-34.5	57	23002	6.3 (5.9-6.7)	97.4 (97.1-97.8)	< 0.001	0.853
Cross-sectional	9.2 (6.9-11.9)	0-34.6	56	22867	6.3 (5.9-6.7)	97.5 (97.1-97.8)	< 0.001	0.851
Low risk of bias	7 (4-10.8)	0-30.3	20	10408	6.4 (5.7-7.1)	97.6 (97-98)	< 0.001	0.463

¹H is a measure of the extent of heterogeneity, a value of H =1 indicates homogeneity of effects and a value of H > 1 indicates a potential heterogeneity of effects.

²I² describes the proportion of total variation in study estimates that is due to heterogeneity, a value > 50% indicates presence of heterogeneity.

HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis e antigen; CI: Confidence interval; NA: Not available.

Citation: Mahamat G, Kenmoe S, Akazong EW, Ebogo-Belobo JT, Mbaga DS, Bowo-Ngandji A, Foe-Essomba JR, Amougou-Atsama M, Monamele CG, Mbongue Mikangue CA, Kame-Ngasse GI, Magoudjou-Pekam JN, Zemnou-Tepap C, Meta-Djomsi D, Maïdadi-Foudi M, Touangnou-Chamda SA, Daha-Tchoffo AG, Selly-Ngaloumo AA, Nayang-Mundo RA, Yéngué JF, Taya-Fokou JB, Fokou LKM, Kenfack-Momo R, Tchami Ngongang D, Atembeh Noura E, Tazokong HR, Demeni Emoh CP, Kengne-Ndé C, Bigna JJ, Boyomo O, Njouom R. Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis. World J Hepatol 2021; 13(9): 1190-1202
URL: https://www.wjgnet.com/1948-5182/full/v13/i9/1190.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i9.1190